Concurrent radiotherapy with gefitinib in elderly patients with esophageal squamous cell carcinoma: Preliminary results of a phase II study

被引:0
作者
Xu, Yaping [1 ]
Zheng, Yuanda [1 ]
Yu, Xinmin [1 ]
Wu, Wei [1 ]
Mao, Weimin [1 ]
机构
[1] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
关键词
D O I
10.1200/jco.2015.33.15_suppl.e15032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15032
引用
收藏
页数:1
相关论文
共 50 条
  • [31] A Prospective Phase II Study of Simultaneous Modulated Accelerated Radiotherapy Concurrently With CDDP/S1 for Esophageal Squamous Cell Carcinoma in the Elderly
    Guo, SuPing
    Liu, FangJie
    Liu, Hui
    Wu, YingJia
    Zhang, XuHui
    Ye, WenFeng
    Luo, GuangYu
    Li, QiWen
    Chen, NaiBin
    Hu, Nan
    Wang, Bin
    Zhang, Jun
    Lin, MaoSheng
    Feng, HuiXia
    Qiu, Bo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [32] A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck
    Lewis, Carol M.
    Glisson, Bonnie S.
    Feng, Lei
    Wan, Fiona
    Tang, Ximing
    Wistuba, Ignacio I.
    El-Naggar, Adel K.
    Rosenthal, David I.
    Chambers, Mark S.
    Lustig, Robert A.
    Weber, Randal S.
    CLINICAL CANCER RESEARCH, 2012, 18 (05) : 1435 - 1446
  • [33] Phase II study of gefitinib in combination with cisplatin and concurrent radiotherapy in patients with stage III/IV squamous cell head and neck cancer and to analyse the effect of gefitinib on tumour gene expression
    Tan, E. H.
    Goh, C.
    Loy, A.
    Leong, S. S.
    Lim, W. T.
    Toh, C. K.
    Tan, T.
    Wee, J.
    Fong, K. W.
    Hui, K. M.
    EJC SUPPLEMENTS, 2008, 6 (12): : 65 - 66
  • [34] Hypofractionated radiotherapy for invasive squamous cell carcinoma of the scalp in the elderly: Efficacy and tolerance, preliminary results
    Jacques, J.
    Renard, S.
    Demogeot, N.
    Faivre, J. C.
    Peiffert, D.
    CANCER RADIOTHERAPIE, 2023, 27 (04): : 290 - 295
  • [35] Radiochemotherapy for Esophageal Squamous Cell Carcinoma in Elderly Patients
    Hagiwara, Ken
    Kochi, Mitsugu
    Fujii, Masashi
    Song, Keio
    Tamegai, Hidenori
    Watanabe, Megumu
    Takayama, Yuriko
    Suda, Hiroshi
    Teshima, Youichi
    Takayama, Tadatoshi
    HEPATO-GASTROENTEROLOGY, 2014, 61 (134) : 1617 - 1622
  • [36] A phase II study of apatinib in patients with recurrent/metastatic esophageal squamous cell carcinoma (ESCC)
    Chu, L.
    Liang, F.
    Zhang, J.
    Deng, J.
    Chen, Y.
    Liu, Q.
    Ai, D.
    Zhu, Z.
    Zhao, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [37] Neoadjuvant nedaplatin and paclitaxel regimen with concurrent radiotherapy for esophageal squamous cell carcinoma: A single-arm phase II clinical trial
    Liu, T.
    Xiao, D.
    Li, Q.
    Chen, Y.
    Tian, J.
    Lin, Z.
    Ding, Z.
    ANNALS OF ONCOLOGY, 2023, 34 : S35 - S35
  • [38] Phase II Trial of Intensity-Modulated Radiotherapy Concurrent With Chemotherapy for Postoperative Node-Positive Esophageal Squamous Cell Carcinoma
    Tao, Hua
    Zhou, Yiqin
    Yao, Chengyun
    Gu, Dayong
    Chen, Wei
    Lu, Jincheng
    ONCOLOGY RESEARCH, 2017, 25 (08) : 1357 - 1362
  • [39] The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma
    H. Yin
    M. E
    H. Zhang
    C. Wang
    Clinical and Translational Oncology, 2017, 19 : 742 - 749
  • [40] The outcomes of radiotherapy and factors that predict overall survival in elderly patients with esophageal squamous cell carcinoma
    Yin, H.
    E, M.
    Zhang, H.
    Wang, C.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (06) : 742 - 749